BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most promising future stocks to buy now. Piper Sandler revised the ...

There's no need to hurry in buying this biotech stock.

US biotech BioMarin Pharmaceutical (Nasdaq: BMRN) has priced an $850 million offering of 5.5% senior unsecured notes due 2034 ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Best Cheap Stocks to Buy Right Now. Barclays initiated coverage of BioMarin on January 28, assigning it an “Overweight” rating and a target ...

BioMarin Pharmaceutical (NasdaqGS:BMRN) announced a major debt financing package to support its pending acquisition of Amicus ...

Shortly after taking the reins at BioMarin, CEO Alexander Hardy laid out three paths the company could take for its struggling hemophilia A gene therapy, Roctavian. A year after opting to shrink the ...

On Friday, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) agreed to acquire Amicus Therapeutics, Inc. (NASDAQ: FOLD) for a total equity value of about $4.8 billion. "Immediately upon close, this ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. BioMarin Pharmaceutical (Nasdaq: BMRN) missed both ...

BioMarin to Gain Galafold ® (migalastat) for Fabry Disease and Pombiliti ® (cipaglucosidase alfa-atga) + Opfolda ® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with $599 ...

We came across a bullish thesis on BioMarin Pharmaceutical Inc. on Value investing subreddit by BearWithMeGM. In this article, we will summarize the bulls’ thesis on BMRN. BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is one of the most promising future stocks to buy now. Piper Sandler revised the price target on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to $84 from $122 ...